In a report released today, Alexander Nowak from Craig-Hallum maintained a Buy rating on Tandem Diabetes Care (TNDM – Research Report). The company’s shares closed yesterday at $31.14.
According to TipRanks, Nowak is a 3-star analyst with an average return of 1.3% and a 42.63% success rate. Nowak covers the Healthcare sector, focusing on stocks such as QuidelOrtho, CareDx, and CVRx.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Tandem Diabetes Care with a $31.18 average price target, which is a 0.13% upside from current levels. In a report released on February 22, Barclays also maintained a Buy rating on the stock with a $39.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
TNDM market cap is currently $2.04B and has a P/E ratio of -9.06.
Based on the recent corporate insider activity of 99 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of TNDM in relation to earlier this year. Most recently, in January 2024, Rajwant Sodhi, a Director at TNDM bought 1,070.00 shares for a total of $29,596.20.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Tandem Diabetes Care (TNDM) Company Description:
Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its flagship product, t:slim X2 Insulin Delivery System, operates as a small insulin pump. The company was founded by Paul M. DiPerna on January 27, 2006 and is headquartered in San Diego, CA.
Read More on TNDM:
- Tandem Diabetes (NASDAQ:TNDM): Investors Look to Innovation to Drive the Stock Higher
- Tandem Diabetes sees Q1 revenue $175M, consensus $186.09M
- Tandem Diabetes sees FY24 non-GAAP revenue roughly $850M, consensus $842.49M
- Tandem Diabetes reports Q4 adjusted EPS (46c), consensus (25c)
- TNDM Earnings this Week: How Will it Perform?
